Role of transarterial chemoembolization in relation with sorafenib for patients with advanced hepatocellular carcinoma

BACKGROUND: Although sorafenib is considered standard therapy for advanced hepatocellular carcinoma (HCC), actual treatments vary. We evaluated the effects of different treatment strategies on overall survival. METHODS: A retrospective study of sorafenib-treated patients with advanced HCC was conduc...

Descripción completa

Detalles Bibliográficos
Autores principales: Ha, Yeonjung, Lee, Danbi, Shim, Ju Hyun, Lim, Young-Suk, Lee, Han Chu, Chung, Young-Hwa, Lee, Yung Sang, Park, Sook Ryun, Ryu, Min-Hee, Ryoo, Baek-Yeol, Kang, Yoon-Koo, Kim, Kang Mo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342054/
https://www.ncbi.nlm.nih.gov/pubmed/27494871
http://dx.doi.org/10.18632/oncotarget.11030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342054/
https://www.ncbi.nlm.nih.gov/pubmed/27494871
http://dx.doi.org/10.18632/oncotarget.11030

Ejemplares similares